Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CytomX Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CTMX
Nasdaq
2836
www.cytomx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CytomX Therapeutics, Inc.
Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago
- Jan 29th, 2025 2:21 pm
AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer
- Jan 20th, 2025 7:05 pm
PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales
- Jan 13th, 2025 4:43 pm
CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Jan 8th, 2025 1:00 pm
All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy
- Jan 7th, 2025 5:00 pm
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
- Jan 6th, 2025 9:05 pm
KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates
- Jan 6th, 2025 1:59 pm
Here's Why Arcutis Stock More Than Doubled in Market Value in One Year
- Jan 3rd, 2025 6:28 pm
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
- Jan 3rd, 2025 3:56 pm
CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA
- Jan 3rd, 2025 3:23 pm
Neumora Stock Hits Record Low on Depression Drug Study Failure
- Jan 3rd, 2025 2:14 pm
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
- Jan 2nd, 2025 6:28 pm
VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag
- Jan 2nd, 2025 2:56 pm
CytomX Therapeutics (CTMX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- Dec 16th, 2024 2:55 pm
Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday
- Dec 12th, 2024 4:00 pm
Grifols Stock Declines After Brookfield Drops Buyout Offer
- Nov 28th, 2024 3:02 pm
CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
- Nov 27th, 2024 1:00 pm
AstraZeneca's Combination Therapy Meets Goal in Prostate Cancer Study
- Nov 26th, 2024 7:18 pm
JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer
- Nov 21st, 2024 5:08 pm
Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%
- Nov 20th, 2024 2:30 pm
Scroll